PerSimiO ⚠ Under review

Under review — some data on this profile may be inaccurate and is being re-verified.

PerSimiO offers a superior prediction technology, based on proprietary simulation of the response of human bones to load.

Health Tech & Life Sciences
Active
Pre-Funding Be'er Sheva, Israel Founded 2016
Website ↗
Last updated 2026-07-20
Total raised
$955K
Last: Grant 2017-08
Stage
Pre-Funding
Founded
2016
Headcount
9
HQ
Be'er Sheva, Israel
Sector
Health Tech & Life Sciences

About

PerSimiO Ltd. is an Israeli startup company focused on commercializing fifteen years of academic research and development in bone biomechanical simulation. The company provides a superior prediction technology, Simfini, which uses intelligent machine learning, finite element analysis, and computational biomechanics to simulate the response of human bones to load. This technology generates bone quality and strength assessments with high reliability, aiming to improve healthcare decisions and reduce unnecessary surgeries. PerSimiO's patented technology is a fully automated web-service that can be integrated into hospital PACS or accessed as a locally hosted web-application.

Funding history · 2 rounds · $955K total

2017-07
Grant $426K
2015-09
Grant $529K

Headcount over time

From 8 (2018-08) to 3 (2023-07) · -5 (-62%) · 10 points · source: Finder history + radar grounding
80 2018-08 2023-07

Q&A

What is PerSimiO's primary focus?
PerSimiO specializes in predicting fracture risk for patients with cancer and osteoporosis using proprietary simulation technology that analyzes the response of human bones to load.
When was PerSimiO founded?
PerSimiO was founded in January 2015.
What is PerSimiO's total funding to date?
PerSimiO has raised a total of $955,000 through grant funding.
When was PerSimiO's last funding round and who participated?
PerSimiO's last funding round was a Grant in August 2017, with participation from the Israel Innovation Authority.
Who are the co-founders of PerSimiO?
The co-founders of PerSimiO are Prof. Zohar Yosibash (Co-founder & CEO), Dr. Nir Trabelsi, and Prof. MD Charles Milgrom. Eitan Segall was also a co-founder but is no longer with the company.
What is the primary sector of PerSimiO?
PerSimiO's primary sector is Health Tech & Life Sciences.
Does PerSimiO hold any patents?
Yes, PerSimiO holds one patent for its technology.

Team · 3

Zohar Yosibash
Founder · Founder, Chief Technology Officer
Charles Milgrom
Founder · Founder, Chief Medical Officer
Kent Myers
Founder · Founder, Chief Software Engineer

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision Support
Technologies
Platforms & InterfacesSoftwareArtificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

orthopedicssimulationdigital-healthcaresaasbonesoftware-applicationsdata-analyticshealthcare-providersdoctorsmachine-learninghospitalspredictive-analyticsartificial-intelligencediabetesimagingdecision-supporttreatmentsrisk-assesmentsct-scan
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitepersimio.com
YouTubeyoutube.com/channel/UCv5X2jDm9uj18AMmRH1WtmQ

Identifiers & details

Legal namePerSimiO Ltd.
Founded2016-1
Employees (exact)9

Radar intelligence

Patents

EPO2

Publications (Crossref)

Works3

Web history (Wayback)

Domainpersimio.com

Certificate / subdomain footprint

Subdomains3

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)515190593
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2015-01-14
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)yes
Last annual report2022
Active charges / liens0
Registry events1 — other (1)
Registered addressהאנרגיה 77 באר שבע

Recent registry events

DateEvent
2025-12-10עדכון חיובים במג~ק